According to XYZResearch's analysis,in the last several years, Global market of Eculizumab developed rapidly, with an average growth rate of 34%. In 2016, Global Revenue of Eculizumab was nearly 2850 M USD; the actual production was about 460 thousand units.
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
The classification of Eculizumab includes Plasma Exchange and Plasma Infusion, and the proportion of Plasma Exchange in 2016 was about 72%, and the proportion was in increasing trend from 2012 to 2016.
Eculizumab is widely used for patients of PNH, aHUS and others. The most proportion of Eculizumab was used for patients of aHUS, and the proportion in 2016 was about 55%.
North America was the largest consumption place, with a consumption market share nearly 40.3% in 2016. Following North America, Europe was the second largest consumption place with the consumption market share of 32.6%.
Alexion is the major player in global Eculizumab market. Soliris (eculizumab) is the first and only therapeutic approved for patients with either paroxysmal nocturnal hemoglobinuria (PNH), a lifethreatening and ultra-rare genetic blood disorder, or atypical hemolytic uremic syndrome (aHUS), a life-threatening and ultra-rare genetic disease. PNH and aHUS result from chronic uncontrolled activation of the complement component of the immune system.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of Eculizumab in these regions, from 2014 to 2026 (forecast), covering
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
South America (Brazil, Argentina, Columbia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global Eculizumab market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Alexion
...
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Plasma Exchange
Plasma Infusion
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Eculizumab for each application, including
PNH
aHUS
Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
Global Eculizumab Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Eculizumab Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Plasma Exchange Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Plasma Infusion Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific Eculizumab Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America Eculizumab Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe Eculizumab Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America Eculizumab Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa Eculizumab Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World Eculizumab Market Assessment by Type
8.1 Asia Pacific Eculizumab Market Assessment by Application (Consumption and Market Share)
8.2 North America Eculizumab Market Assessment by Application (Consumption and Market Share)
8.3 Europe Eculizumab Market Assessment by Application (Consumption and Market Share)
8.4 South America Eculizumab Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa Eculizumab Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Alexion
9.1.1 Alexion Profiles
9.1.2 Alexion Product Portfolio
9.1.3 Alexion Eculizumab Business Performance
9.1.4 Alexion Eculizumab Business Development and Market Status
10 World Eculizumab Market Assessment by Players
10.1 Global Eculizumab Sales (K Units) and Market Share by Players 2014-2020
10.2 Global Eculizumab Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global Eculizumab Price (USD/Unit) of Players 2014-2020
10.4 Global Eculizumab Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America Eculizumab Sales Assessment of Players 2014-2020
11.1.2 North America Eculizumab Revenue Assessment of Players 2014-2020
11.1.3 North America Eculizumab Price Assessment of Players 2014-2020
11.1.4 North America Eculizumab Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe Eculizumab Sales Assessment of Players 2014-2020
11.2.2 Europe Eculizumab Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe Eculizumab Price Assessment of Players 2014-2020
11.2.4 Europe Eculizumab Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific Eculizumab Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific Eculizumab Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific Eculizumab Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific Eculizumab Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America Eculizumab Sales Assessment of Players 2014-2020
11.4.2 South America Eculizumab Revenue Assessment of Players 2014-2020
11.4.3 South America Eculizumab Price Assessment of Players 2014-2020
11.4.4 South America Eculizumab Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa Eculizumab Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa Eculizumab Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa Eculizumab Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa Eculizumab Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific Eculizumab Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific Eculizumab Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific Eculizumab Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America Eculizumab Sales by Countries/Regions 2014-2020
12.2.2 North America Eculizumab Revenue by Countries/Regions 2014-2020
12.2.3 North America Eculizumab Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe Eculizumab Sales by Countries/Regions 2014-2020
12.3.2 Europe Eculizumab Revenue by Countries/Regions 2014-2020
12.3.3 Europe Eculizumab Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America Eculizumab Sales by Countries/Regions 2014-2020
12.4.2 South America Eculizumab Revenue by Countries/Regions 2014-2020
12.4.3 South America Eculizumab Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa Eculizumab Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa Eculizumab Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa Eculizumab Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World Eculizumab Sales & Revenue Forecast 2021-2026
14.1 World Eculizumab Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World EculizumabSales and Market Share by Regions
14.1.2 World EculizumabRevenue and Market Share by Regions
15 Asia Eculizumab Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Plasma Exchange
15.1.2 Plasma Infusion
15.2 Consumption Forecast by Application, 2021-2026
16 North America Eculizumab Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Plasma Exchange
16.1.2 Plasma Infusion
16.2 Consumption Forecast by Application, 2021-2026
17 Europe Eculizumab Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Plasma Exchange
17.1.2 Plasma Infusion
17.2 Consumption Forecast by Application, 2021-2026
18 South America Eculizumab Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Plasma Exchange
18.1.2 Plasma Infusion
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa Eculizumab Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Plasma Exchange
19.1.2 Plasma Infusion
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global Eculizumab Price (USD/Unit) Trend 2021-2026
20.2 Global Eculizumab Gross Profit Trend 2021-2026
21 Conclusion
List of Tables and Figures
Figure Product Picture of Eculizumab
Table Players List in the Report
Table Mergers & Acquisitions, Expansion Plans
Table Global Eculizumab Market Size (Volume) and Growth Rate by Type (2019-2026)
Global Eculizumab Market Share by Application (2019-2026)
Figure Industry Chain Structure of Eculizumab
Table Product Application and Standard
Table Key Suppliers of Raw Material/Components
Figure Industry Chain Structure of Eculizumab
Table Representative Downstream Enterprises of Eculizumab
Figure New Project SWOT Analysis of Eculizumab
Table Industry Policy List of Eculizumab 2019
Table World Eculizumab Sales (Unit) by Type (2014-2020)
Figure World Eculizumab Sales Market Share (%) by Type 2014-2020
Table World 2014-2020 Eculizumab Revenue (M USD) by Type
Figure World Eculizumab Revenue Market Share (%) by Type 2014-2020
Table Plasma Exchange-Sales (K Units), Revenue and Growth Rate
Table Plasma Infusion-Sales (K Units), Revenue and Growth Rate
Table Asia Pacific Eculizumab Sales by Type (2014-2020)
Figure Asia Pacific Eculizumab Sales Market Share by Type (2014-2020)
Table Asia Pacific Eculizumab Revenue by Type (2014-2020)
Figure Asia Pacific Eculizumab Revenue Market Share by Type (2014-2020)
Table Key Players in Asia Pacific
Table North America Eculizumab Sales by Type (2014-2020)
Figure North America Eculizumab Sales Market Share by Type (2014-2020)
Table North America Eculizumab Revenue by Type (2014-2020)
Figure North America Eculizumab Revenue Market Share by Type (2014-2020)
Table Key Players in North America
Table Europe Eculizumab Sales by Type (2014-2020)
Figure Europe Eculizumab Sales Market Share by Type (2014-2020)
Table Europe Eculizumab Revenue by Type (2014-2020)
Figure Europe Eculizumab Revenue Market Share by Type (2014-2020)
Table Key Players in Europe
Table South America Eculizumab Sales by Type (2014-2020)
Figure South America Eculizumab Sales Market Share by Type (2014-2020)
Table South America Eculizumab Revenue by Type (2014-2020)
Figure South America Eculizumab Revenue Market Share by Type (2014-2020)
Table Key Players in South America
Table Middle East and Africa Eculizumab Sales by Type (2014-2020)
Figure Middle East and Africa Eculizumab Sales Market Share by Type (2014-2020)
Table Middle East and Africa Eculizumab Revenue by Type (2014-2020)
Figure Middle East and Africa Eculizumab Revenue Market Share by Type (2014-2020)
Table Key Players in Middle East and Africa
Table World Eculizumab Consumption by Application (2014-2020)
Table World Eculizumab Consumption Market Share by Application (2014-2020)
Table Asia Eculizumab Consumption by Application (2014-2020)
Table Asia Eculizumab Consumption Market Share by Application (2014-2020)
Table North America Eculizumab Consumption by Application (2014-2020)
Table North America Eculizumab Consumption Market Share by Application (2014-2020)
Table Europe Eculizumab Consumption by Application (2014-2020)
Table Europe Eculizumab Consumption Market Share by Application (2014-2020)
Table South America Eculizumab Consumption by Application (2014-2020)
Table South America Eculizumab Consumption Market Share by Application (2014-2020)
Table Middle East and Africa Eculizumab Consumption by Application (2014-2020)
Table Middle East and Africa Eculizumab Consumption Market Share by Application (2014-2020)
Table Alexion Profiles
Table Alexion Product Information
Table Alexion Eculizumab Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Alexion Eculizumab Sales Market Share 2014-2020
Table Alexion Eculizumab Market Status Change 2014-2020
Table Sales (Unit) of Players (2014-2020)
Table Sales Share of Players (2014-2020)
Figure World Eculizumab Sales Share in 2019
Table Revenue of Players (2014-2020)
Table Revenue Share of Players (2014-2020)
Figure World Eculizumab Revenue Share in 2019
Table Average Price of Players (2014-2020)
Figure Average Price of Players (2014-2020)
Table Gross Margin of Players (2014-2020)
Figure Gross Margin of Players in 2014
Figure Gross Margin of Players in 2019
Figure World Market Concentration (2014-2019)
Table Top 5 Players Sales Share (2014-2019)
Table Asia Pacific Eculizumab Sales (Unit) of Players (2014-2019)
Table Asia Pacific Eculizumab Sales Share of Players (2014-2019)
Figure Asia Pacific Eculizumab Sales Share in 2019
Table Asia Pacific Eculizumab Revenue of Players (2014-2019)
Table Asia Pacific Eculizumab Revenue Share of Players (2014-2019)
Figure Asia Pacific Eculizumab Revenue Share in 2019
Table Asia Pacific Eculizumab Price of Players (2014-2019)
Table Asia Pacific Eculizumab Gross Margin of Players (2014-2019)
Figure Asia Pacific Eculizumab Gross Margin Share in 2019
Figure Asia Pacific Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table North America Eculizumab Sales (Unit) of Players (2014-2019)
Table North America Eculizumab Sales Share of Players (2014-2019)
Figure North America Eculizumab Sales Share in 2019
Table North America Eculizumab Revenue of Players (2014-2019)
Table North America Eculizumab Revenue Share of Players (2014-2019)
Figure North America Eculizumab Revenue Share in 2019
Table North America Eculizumab Price of Players (2014-2019)
Table North America Eculizumab Gross Margin of Players (2014-2019)
Figure North America Eculizumab Gross Margin Share in 2019
Figure North America Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Europe Eculizumab Sales (Unit) of Players (2014-2019)
Table Europe Eculizumab Sales Share of Players (2014-2019)
Figure Europe Eculizumab Sales Share in 2019
Table Europe Eculizumab Revenue of Players (2014-2019)
Table Europe Eculizumab Revenue Share of Players (2014-2019)
Figure Europe Eculizumab Revenue Share in 2019
Table Europe Eculizumab Price of Players (2014-2019)
Table Europe Eculizumab Gross Margin of Players (2014-2019)
Figure Europe Eculizumab Gross Margin Share in 2019
Figure Europe Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table South America Eculizumab Sales (Unit) of Players (2014-2019)
Table South America Eculizumab Sales Share of Players (2014-2019)
Figure South America Eculizumab Sales Share in 2019
Table South America Eculizumab Revenue of Players (2014-2019)
Table South America Eculizumab Revenue Share of Players (2014-2019)
Figure South America Eculizumab Revenue Share in 2019
Table South America Eculizumab Price of Players (2014-2019)
Table South America Eculizumab Gross Margin of Players (2014-2019)
Figure South America Eculizumab Gross Margin Share in 2019
Figure South America Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Middle East and Africa Eculizumab Sales (Unit) of Players (2014-2019)
Table Middle East and Africa Eculizumab Sales Share of Players (2014-2019)
Figure Middle East and Africa Eculizumab Sales Share in 2019
Table Middle East and Africa Eculizumab Revenue of Players (2014-2019)
Table Middle East and Africa Eculizumab Revenue Share of Players (2014-2019)
Figure Middle East and Africa Eculizumab Revenue Share in 2019
Table Middle East and Africa Eculizumab Price of Players (2014-2019)
Table Middle East and Africa Eculizumab Gross Margin of Players (2014-2019)
Figure Middle East and Africa Eculizumab Gross Margin Share in 2019
Figure Middle East and Africa Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Asia Pacific Eculizumab Sales by Countries/Region (2014-2020)
Figure Asia Pacific Eculizumab Sales and Growth Rate (2014-2020)
Table Asia Pacific Eculizumab Sales Share by Countries/Region (2014-2020)
Figure Asia Pacific Eculizumab Sales Share by Countries/Region in 2019
Table Asia Pacific Eculizumab Revenue (Million USD) by Countries (2014-2020)
Figure Asia Pacific Eculizumab Revenue and Growth Rate (2014-2020)
Table Asia Pacific Eculizumab Revenue Share by Countries/Region (2014-2020)
Figure Asia Pacific Eculizumab Revenue Share by Countries/Region in 2019
Table Asia Pacific Eculizumab Average Price (USD/Unit) by Countries (2014-2020)
Table North America Eculizumab Sales by Countries/Region (2014-2020)
Figure North America Eculizumab Sales and Growth Rate (2014-2020)
Table North America Eculizumab Sales Share by Countries/Region (2014-2020)
Figure North America Eculizumab Sales Share by Countries/Region in 2019
Table North America Eculizumab Revenue (Million USD) by Countries (2014-2020)
Figure North America Eculizumab Revenue and Growth Rate (2014-2020)
Table North America Eculizumab Revenue Share by Countries/Region (2014-2020)
Figure North America Eculizumab Revenue Share by Countries/Region in 2019
Table North America Eculizumab Average Price (USD/Unit) by Countries (2014-2020)
Table Europe Eculizumab Sales by Countries/Region (2014-2020)
Figure Europe Eculizumab Sales and Growth Rate (2014-2020)
Table Europe Eculizumab Sales Share by Countries/Region (2014-2020)
Figure Europe Eculizumab Sales Share by Countries/Region in 2019
Table Europe Eculizumab Revenue (Million USD) by Countries (2014-2020)
Figure Europe Eculizumab Revenue and Growth Rate (2014-2020)
Table Europe Eculizumab Revenue Share by Countries/Region (2014-2020)
Figure Europe Eculizumab Revenue Share by Countries/Region in 2019
Table Europe Eculizumab Average Price (USD/Unit) by Countries (2014-2020)
Table South America Eculizumab Sales by Countries/Region (2014-2020)
Figure South America Eculizumab Sales and Growth Rate (2014-2020)
Table South America Eculizumab Sales Share by Countries/Region (2014-2020)
Figure South America Eculizumab Sales Share by Countries/Region in 2019
Table South America Eculizumab Revenue (Million USD) by Countries (2014-2020)
Figure South America Eculizumab Revenue and Growth Rate (2014-2020)
Table South America Eculizumab Revenue Share by Countries/Region (2014-2020)
Figure South America Eculizumab Revenue Share by Countries/Region in 2019
Table South America Eculizumab Average Price (USD/Unit) by Countries (2014-2020)
Table Middle East and Africa Eculizumab Sales by Countries/Region (2014-2020)
Figure Middle East and Africa Eculizumab Sales and Growth Rate (2014-2020)
Table Middle East and Africa Eculizumab Sales Share by Countries/Region (2014-2020)
Figure Middle East and Africa Eculizumab Sales Share by Countries/Region in 2019
Table Middle East and Africa Eculizumab Revenue (Million USD) by Countries (2014-2020)
Figure Middle East and Africa Eculizumab Revenue and Growth Rate (2014-2020)
Table Middle East and Africa Eculizumab Revenue Share by Countries/Region (2014-2020)
Figure Middle East and Africa Eculizumab Revenue Share by Countries/Region in 2019
Table Middle East and Africa Eculizumab Average Price (USD/Unit) by Countries (2014-2020)
Table Key Opportunities and Drivers
Table World Eculizumab Sales (Unit) by Regions (2020-2025)
Figure World Eculizumab Sales (Unit) and Growth Rate (2020-2025)
Table World Eculizumab Sales Share by Regions (2020-2025)
Figure World Eculizumab Sales Share by Regions in 2025
Table World Eculizumab Revenue by Regions (2020-2025)
Figure World Eculizumab Revenue and Growth Rate (2020-2025)
Table World Eculizumab Revenue Share by Regions (2020-2025)
Figure World Eculizumab Revenue Share by Regions in 2025
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Figure Sales (Unit) and Growth Rate (2020-2025)
Figure Revenue (Million USD) and Growth Rate (2020-2025)
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Figure Sales (Unit) and Growth Rate (2020-2025)
Figure Revenue (Million USD) and Growth Rate (2020-2025)
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Table Consumption (K Units) Forecast by Application (2020-2025)
Figure Consumption (K Units) Forecast by Application (2020-2025)
Figure World Price (USD/Unit) Trend (2020-2025)
Figure World Gross Profit Trend (2020-2025)
